Shenglan Tan

632 total citations
29 papers, 444 citations indexed

About

Shenglan Tan is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Complementary and alternative medicine. According to data from OpenAlex, Shenglan Tan has authored 29 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Complementary and alternative medicine. Recurrent topics in Shenglan Tan's work include Medicinal plant effects and applications (5 papers), Natural product bioactivities and synthesis (4 papers) and Biological Activity of Diterpenoids and Biflavonoids (3 papers). Shenglan Tan is often cited by papers focused on Medicinal plant effects and applications (5 papers), Natural product bioactivities and synthesis (4 papers) and Biological Activity of Diterpenoids and Biflavonoids (3 papers). Shenglan Tan collaborates with scholars based in China, United States and Canada. Shenglan Tan's co-authors include Bikui Zhang, Ping Xu, Yang Deng, Pei Jiang, Yangzhao Zhou, Qiong Lu, Daxiong Xiang, Elijah Paintsil, Zhaohui Zhong and Yung‐Chi Cheng and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Pharmacology and European Journal of Pharmacology.

In The Last Decade

Shenglan Tan

26 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenglan Tan China 13 196 65 65 62 59 29 444
Liping Ma China 18 229 1.2× 47 0.7× 41 0.6× 17 0.3× 136 2.3× 41 682
Zhiying Luo China 16 236 1.2× 22 0.3× 51 0.8× 53 0.9× 86 1.5× 40 717
Bashir A. Yousef Sudan 14 208 1.1× 132 2.0× 33 0.5× 32 0.5× 106 1.8× 69 553
Ruijuan Liu China 12 151 0.8× 28 0.4× 78 1.2× 37 0.6× 75 1.3× 37 503
Quansheng Feng China 11 203 1.0× 40 0.6× 28 0.4× 57 0.9× 43 0.7× 54 461
Yuanfei Huang China 11 124 0.6× 89 1.4× 43 0.7× 38 0.6× 229 3.9× 18 607
Heping Lei China 13 111 0.6× 75 1.2× 114 1.8× 33 0.5× 174 2.9× 20 514
Richard Fux Germany 10 196 1.0× 30 0.5× 30 0.5× 33 0.5× 137 2.3× 16 540
Miguel Ángel Calleja Spain 14 142 0.7× 19 0.3× 19 0.3× 27 0.4× 60 1.0× 43 640
Pazit Y. Cohen Israel 7 261 1.3× 18 0.3× 23 0.4× 43 0.7× 56 0.9× 9 624

Countries citing papers authored by Shenglan Tan

Since Specialization
Citations

This map shows the geographic impact of Shenglan Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Tan more than expected).

Fields of papers citing papers by Shenglan Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglan Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Tan. The network helps show where Shenglan Tan may publish in the future.

Co-authorship network of co-authors of Shenglan Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglan Tan. A scholar is included among the top collaborators of Shenglan Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglan Tan. Shenglan Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Xiao, Jie, Lei Chen, Qing Wang, et al.. (2024). Interpretable time-series neural turing machine for prognostic prediction of patients with type 2 diabetes in physician-pharmacist collaborative clinics. International Journal of Medical Informatics. 195. 105737–105737.
4.
Li, Tianyu, et al.. (2023). Dihydromyricetin Inhibits M1 Macrophage Polarization in Atherosclerosis by Modulating miR-9-Mediated SIRT1/NF-κB Signaling Pathway. Mediators of Inflammation. 2023. 1–11. 11 indexed citations
5.
Xiao, Jie, Qing Wang, Shenglan Tan, et al.. (2023). Analysis of patient medication compliance and quality of life of physician-pharmacist collaborative clinics for T2DM management in primary healthcare in China: A mixed-methods study. Frontiers in Pharmacology. 14. 1098207–1098207. 8 indexed citations
6.
7.
Li, Xin, et al.. (2021). Dihydromyricetin Inhibits Tumor Growth and Epithelial-Mesenchymal Transition through regulating miR-455-3p in Cholangiocarcinoma. Journal of Cancer. 12(20). 6058–6070. 9 indexed citations
8.
9.
Gong, Jinyu, Kai Xing, Fan Li, et al.. (2021). Evaluating the role of GSTP1 genetic polymorphism (rs1695, 313A>G) as a predictor in cyclophosphamide-induced toxicities. Medicine. 100(11). e24423–e24423. 9 indexed citations
10.
11.
Tan, Shenglan, Bikui Zhang, & Ping Xu. (2020). Chinese pharmacists’ rapid response to the COVID-19 outbreak. American Journal of Health-System Pharmacy. 77(14). 1096–1097. 16 indexed citations
12.
Li, Wen‐Qun, Shenglan Tan, Xiaohui Li, et al.. (2018). Calcitonin gene-related peptide inhibits the cardiac fibroblasts senescence in cardiac fibrosis via up-regulating klotho expression. European Journal of Pharmacology. 843. 96–103. 48 indexed citations
13.
Ren, Huan, Shenglan Tan, Mou-Ze Liu, Hoan Linh Banh, & Jian‐Quan Luo. (2018). Association of PON2 Gene Polymorphisms (Ser311Cys and Ala148Gly) With the Risk of Developing Type 2 Diabetes Mellitus in the Chinese Population. Frontiers in Endocrinology. 9. 495–495. 4 indexed citations
14.
Wang, Kai, Shenglan Tan, Qiong Lu, et al.. (2018). Curcumin Suppresses microRNA-7641-Mediated Regulation of p16 Expression in Bladder Cancer. The American Journal of Chinese Medicine. 46(6). 1357–1368. 41 indexed citations
15.
Li, Ziwei, Fenghua Peng, Miao Yan, et al.. (2017). Impact of CYP2C19 Genotype and Liver Function on Voriconazole Pharmacokinetics in Renal Transplant Recipients. Therapeutic Drug Monitoring. 39(4). 422–428. 50 indexed citations
16.
17.
Zhan, Min, Qiang Qu, Guo Wang, et al.. (2013). Let-7c Inhibits NSCLC Cell Proliferation by Targeting HOXA1. Asian Pacific Journal of Cancer Prevention. 14(1). 387–392. 17 indexed citations
18.
Tan, Shenglan, Zhi Li, Wei Zhang, et al.. (2013). Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacement. European Journal of Clinical Pharmacology. 69(10). 1769–1775. 12 indexed citations
19.
Kim, Byung Ju, Jinhua Zhang, Shenglan Tan, et al.. (2012). Synthesis and properties of 1-(3′-dihydroxyboryl-2′,3′-dideoxyribosyl)pyrimidines. Organic & Biomolecular Chemistry. 10(47). 9349–9349. 12 indexed citations
20.
Zhang, Wei, Shenglan Tan, Elijah Paintsil, et al.. (2011). Analysis of deoxyribonucleotide pools in human cancer cell lines using a liquid chromatography coupled with tandem mass spectrometry technique. Biochemical Pharmacology. 82(4). 411–417. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liping Ma Breakdown of academic impact, for papers by Zhiying Luo Breakdown of academic impact, for papers by Bashir A. Yousef Breakdown of academic impact, for papers by Ruijuan Liu Breakdown of academic impact, for papers by Quansheng Feng Breakdown of academic impact, for papers by Yuanfei Huang Breakdown of academic impact, for papers by Heping Lei Breakdown of academic impact, for papers by Richard Fux Breakdown of academic impact, for papers by Miguel Ángel Calleja Breakdown of academic impact, for papers by Pazit Y. Cohen
Rankless by CCL
2026